Unveiling the Potential of Humatrope in Treating Short Bowel Syndrome: A Comprehensive Review
Reading Time: 2 minutesIntroduction Short Bowel Syndrome (SBS) represents a significant challenge in gastroenterology, characterized by the malabsorptive state following extensive resection of the small intestine. The management of SBS is multifaceted, aiming to enhance nutrient absorption and promote intestinal adaptation. Among the various therapeutic options, Humatrope, a recombinant human growth hormone, has emerged as a promising adjunct in the management of SBS.... Read more »
